Articles Patient experience: living with glaucoma This week is World Glaucoma Week, held annually to raise awareness of eye disease glaucoma, which is the most common cause of irreversible blindness in the world today.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.